Correlation Between Recursion Pharmaceuticals and EMERA

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and EMERA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and EMERA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and EMERA FIN LP, you can compare the effects of market volatilities on Recursion Pharmaceuticals and EMERA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of EMERA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and EMERA.

Diversification Opportunities for Recursion Pharmaceuticals and EMERA

-0.23

Correlation Coefficient

Recursion Pharmaceuticals  EMERA

Very good diversification

The 3 months correlation between Recursion and EMERA is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and EMERA FIN LP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EMERA FIN LP and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with EMERA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EMERA FIN LP has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and EMERA go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and EMERA

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 5.24 times more return on investment than EMERA. However, Recursion Pharmaceuticals is 5.24 times more volatile than EMERA FIN LP. It trades about 0.0 of its potential returns per unit of risk. EMERA FIN LP is currently generating about -0.04 per unit of risk. If you would invest  1,125  in Recursion Pharmaceuticals on October 7, 2024 and sell it today you would lose (345.00) from holding Recursion Pharmaceuticals or give up 30.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	91.94%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  EMERA FIN LP

Recursion Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

EMERA FIN LP

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days EMERA FIN LP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for EMERA FIN LP investors.

Pair Trading with Recursion Pharmaceuticals and EMERA

The main advantage of trading using opposite Recursion Pharmaceuticals and EMERA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, EMERA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EMERA will offset losses from the drop in EMERA's long position.

The idea behind Recursion Pharmaceuticals and EMERA FIN LP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.